ORLANDO — In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, highlights a presentation on macular telangiectasia type 2.The clinical trials on macular telangiectasia type 2 (MacTel) weighed the design and use o…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discusses 3-year data from the GALE study on geographic atrophy treatment with pegcetacoplan.Stewart said that the study of Syfovre (pegcetacoplan injec…
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, highlights a debate on the use of complement inhibitors in geographic atrophy.In the debate on whether these complement inhibitors are game changers, St…
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press release.Eylea HD (aflibercept 8 mg, Regeneron) is now indicated for treating retinal vein occlusion (RVO) with dosing intervals of up to…
ミラン–(BUSINESS WIRE)–（ビジネスワイヤ） — AGCバイオロジクスは、AAVantgardeによるシリーズB資金調達ラウンドの完了直後も、同バイオテクノロジー企業との新たな製造契約を発表しました。これは、アデノ随伴ウイルス市場におけるAGCバイオロジクスの最新の進展となります。本契約の下、同社は、現在承認された治療法が存在せず、進行性かつ不可逆的な視力低下に対応するために設計されたAAVantgardeの2つの新規候補品について、Good Manufacturing Prac…
On a busy night in the ED, the difference between a controlled resuscitation and a crisis often depends on the people in the room.A trauma patient arrives just as a septic patient starts to decline. A stroke alert goes off while emergency medical servi…